Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

California-based Route 92 Medical previously announced a funding round worth more than $31 million in November. Now, however, a massive addition from Novo Holdings makes the round worth closer to $82 million. 

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure. 

The cloud-based platform identifies and measures cardiac structures in CT scans.

These companies were already part of the Johnson & Johnson family, but they had still retained their previous brand names. Now, each one is officially going by Johnson & Johnson MedTech.